Great Eastern provides complimentary COVID-19 cover for all Singapore residents

spike

Great Eastern has introduced the GREAT Covid Care Plan, a complimentary post-vaccination product available to all residents of Singapore.

This follows the Singapore government’s announcement that it will treat COVID-19 as an endemic disease, meaning that the virus is always present in a certain population or region.

The free coverage will provide a cash payout of SG$200 per day of hospitalisation, up to a total of SG$2,000, in case the policyholder is hospitalised due to COVID-19 even after being vaccinated. The coverage, which is valid for 12 months, includes hospitalisation both in Singapore and abroad.

According to Great Eastern, this will provide additional peace of mind for Singaporeans who may travel abroad for work or leisure, as well as for overseas residents returning to their home country for visits as countries begin opening up their borders.

Any Singapore resident who has completed at least the first dose of a COVID-19 vaccine approved for use by the Health Sciences Authority or supplied under the Special Access Route (SAR) is eligible for the free cover, which can be accessed by registering on Great Eastern’s website.

“We are glad we have been able to help our customers and the community through each phase of the pandemic,” said Great Eastern CEO Khor Hock Seng. “With the steady progress of the vaccination programme in Singapore, the country is well positioned for recovery in this new phase. Many in Singapore have done their part to be vaccinated and as we adapt to an environment where COVID-19 is likely to remain endemic for at least a period of time, we want to continue to do our part to protect our community in Singapore and even when they travel overseas.”

Source Article

Next Post

Largest ever trial of shorter working week posts findings

Workers from a range of professions, from office workers to social service providers, reduced their work week from 40 hours to 35 or 36 hours as part of the project, while receiving the same pay. Research on the trials by UK think-tank Autonomy and Iceland’s Association for Sustainable Democracy (Alda) […]